Dr. Douglas Lee is a staff cardiologist at the Peter Munk Cardiac Centre of the University Health Network, an Associate Professor of Medicine at the University of Toronto, the Cardiovascular Program Lead of the Toronto General Hospital Research Institute and a Senior Scientist at the Institute for Clinical Evaluative Sciences. He obtained his MD and completed postgraduate training in Internal Medicine and Cardiology at the University of Toronto. He then completed a PhD in the section of Clinical Epidemiology in the Department of Health Policy, Management, and Evaluation at the University of Toronto, and a post-doctoral fellowship at the National Heart, Lung, and Blood Institute’s Framingham Heart Study.
Douglas S Lee
Dr. Lee’s research interests include heart failure epidemiology and outcomes, implantable cardioverter defibrillator utilization and outcomes, cardiovascular disease risk factors and prevention, and quality of care and outcomes research.
Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
J Am Heart Assoc. 2017 Aug 19;6(8):
Predictors of obtaining follow-up care in the province of Ontario, Canada, following a new diagnosis of atrial fibrillation, heart failure, and hypertension in the emergency department.
CJEM. 2017 Aug 14;:1-15
Eur J Clin Pharmacol. 2017 Jun 29;:
Associations Between Short or Long Length of Stay and 30-Day Readmission and Mortality in Hospitalized Patients With Heart Failure.
JACC Heart Fail. 2017 May 10;:
The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study.
CMAJ Open. 2017 Apr 25;5(2):E315-E321
Short Length of Stay After Elective Transfemoral Transcatheter Aortic Valve Replacement is Not Associated With Increased Early or Late Readmission Risk.
J Am Heart Assoc. 2017 Apr 24;6(4):
CMAJ. 2017 Apr 03;189(13):E494-E501
The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
Eur J Heart Fail. 2017 Feb 20;:
Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis.
Cancer Treat Rev. 2016 Dec 30;53:120-127
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Medicine, University of Toronto